Testing a Vaccine Against Chagas Disease in Dogs
Author Information
Author(s): Aparicio-Burgos José E., Ochoa-García Laucel, Zepeda-Escobar José Antonio, Gupta Shivali, Dhiman Monisha, Martínez José Simón, de Oca-Jiménez Roberto Montes, Arreola Margarita Val, Barbabosa-Pliego Alberto, Vázquez-Chagoyán Juan C., Garg Nisha Jain
Primary Institution: Centro de Investigación y Estudios Avanzados, Universidad Autónoma de Estado de México, Toluca, México
Hypothesis
Does the multi-component DNA-prime/DNA-boost vaccine TcVac1 provide protection against Trypanosoma cruzi infection in dogs?
Conclusion
The TcVac1 vaccine provided partial resistance to Trypanosoma cruzi infection and Chagas disease in dogs.
Supporting Evidence
- Vaccination with TcVac1 elicited specific antibody responses.
- Vaccinated dogs controlled acute parasitemia better than non-vaccinated dogs.
- TcVac1 did not prevent myocardial parasite burden.
- Electrocardiographic alterations were less severe in vaccinated dogs.
- Vaccinated dogs showed a moderate decline in cardiac alterations during chronic disease.
Takeaway
Researchers tested a vaccine on dogs to see if it could help them fight off a disease caused by a tiny bug. The vaccine helped a little, but not enough to stop the disease completely.
Methodology
Dogs were immunized with the TcVac1 vaccine and then challenged with T. cruzi to assess immune response and disease progression.
Limitations
The vaccine did not prevent peak parasitemia and did not control myocardial parasite burden.
Participant Demographics
Twelve mongrel dogs (6 males and 6 females, 3–4 months old).
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website